Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 21 of 44 for:    "Hemophilia" | "Antibodies"

A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors (STASEY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03191799
Recruitment Status : Active, not recruiting
First Posted : June 19, 2017
Last Update Posted : September 23, 2019
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 4, 2020
Estimated Study Completion Date : September 4, 2020